Zhang, X., Goedegebuure, S. P., Chen, M. Y., Mishra, R., Zhang, F., Yu, Y. Y., . . . Gillanders, W. E. (2024, November). Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients. Genome Medicine.
Chicagoスタイル(17版)引用形式Zhang, Xiuli, et al. "Neoantigen DNA Vaccines Are Safe, Feasible, and Induce Neoantigen-specific Immune Responses in Triple-negative Breast Cancer Patients." Genome Medicine Nov. 2024.
MLA(9版)引用形式Zhang, Xiuli, et al. "Neoantigen DNA Vaccines Are Safe, Feasible, and Induce Neoantigen-specific Immune Responses in Triple-negative Breast Cancer Patients." Genome Medicine, Nov. 2024.
警告: この引用は必ずしも正確ではありません.